Pediatric endocrinology

Lambda-Mu-Sigma (LMS)-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (Soluble RANKL (sRANKL)) and osteoprotegerin (OPG) in the HARP cohort

Osteoporos IntPublished Reference value study

Authors' conclusion

This is the first report of LMS-based continuous pediatric reference percentiles for sRANKL, OPG and sRANKL/OPG ratio that allows calculation of standardized patient z-scores to assess bone metabolic turnover in children.

Study context

Population
Children aged 0.1–18 years, HAnnover Reference values for Pediatrics (HARP) study166 boys
Participants
300 children
Outcome
LMS-based continuous reference percentiles for sRANKL, OPG and sRANKL/OPG ratio
Methodological detailsLMS-based continuous reference percentiles, sRANKL and OPG assessed by ELISA; percentiles generated using RefCurv software
  • LMS-based continuous reference percentiles
  • sRANKL and OPG assessed by ELISA; percentiles generated using RefCurv software

Main finding

As reported in the abstract

LMS-based reference percentiles for sRANKL, OPG and sRANKL/OPG ratio
  • Percentiles for sRANKL, OPG and sRANKL/OPG ratio all age-dependent
  • sRANKL and sRANKL/OPG associated with sex
  • Boys: sRANKL percentiles highest in infancy, continuous decline until age 7 years, second peak around age 12-13 years
  • Girls: continuous slow decline of sRANKL percentiles from infancy until age 13 years, then rapid decline until adulthood
  • OPG percentiles continuously declined from infancy to adulthood
  • sRANKL/OPG ratio percentiles paralleled those of sRANKL

Further findings

Correlates of sRANKL and OPG

Serum sRANKL correlated with OPG and serum phosphate z-scores
P < 0.05
OPG inversely associated with standardized body weight, BMI and urinary phosphate to creatinine ratio
P < 0.05

Original publication

LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort. Osteoporos Int. Published 9 November 2023. doi:10.1007/s00198-023-06959-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.